Newman Amy Hauck

Citée par

	Toutes	Depuis 2020
Citations	17708	5041
indice h	68	37
indice i10	287	145

1200

600

300

900

198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202550 75 95 95 95 97 95 93 95 82 121 143 141 170 183 191 277 303 361 477 481 532 775 864 921 1095 1020 900 934 823 986 879 1103 938 1071 955 88

Accès public

Tout afficher

203 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Jonathan L. KatzNational Institute on Drug AbuseAdresse e-mail validée de nih.gov
Lei ShiNational Institute on Drug Abuse - Intramural Research Program, NIHAdresse e-mail validée de nih.gov
Zheng Xiong XiNIDA, NIHAdresse e-mail validée de mail.nih.gov
Gianluigi TandaStaff scientistAdresse e-mail validée de mail.nih.gov
Ulrik GetherUniversity of CopenhagenAdresse e-mail validée de sund.ku.dk
Thomas M. KeckRowan University, Dept. Chemistry & Biochemistry, Dept. Biological & Biomedical SciencesAdresse e-mail validée de rowan.edu
Claus J. LølandProfessor, University of CopenhagenAdresse e-mail validée de sund.ku.dk
Roxanne VaughanProfessor of Biochemistry University of North DakotaAdresse e-mail validée de med.und.edu
Stephen HusbandsProfessor, Medicinal Chemistry, University of BathAdresse e-mail validée de bath.ac.uk
Harald H. SitteProfessor of Psychopharmacology, Medical University ViennaAdresse e-mail validée de meduniwien.ac.at
Maddalena MereuUniversity of Padua, PD, ItalyAdresse e-mail validée de unipd.it
Vsevolod KatritchUniversity of Southern CaliforniaAdresse e-mail validée de usc.edu
Wayne BowenProfessor of Biology and Chair, Department of Molecular Pharmacology, Physiology & Biotechnology, Brown UniversityAdresse e-mail validée de brown.edu
Gregory T CollinsAssociate Professor; Dept of Pharmacology; UT Health San AntonioAdresse e-mail validée de uthscsa.edu
Michael FreissmuthMedical University of ViennaAdresse e-mail validée de meduniwien.ac.at
Harel WeinsteinProfessor of Professor of Physiology and Biophysics, Weill Cornell Medicine, Cornell U.Adresse e-mail validée de med.cornell.edu
Jacob EriksenNine Square TherapeuticsAdresse e-mail validée de ninesquaretx.com
James FosterUniversity of North Dakota School of Medicine and Health SciencesAdresse e-mail validée de med.und.edu
Prof. T.W. RobbinsUniversity of CambridgeAdresse e-mail validée de cam.ac.uk
Raymond StevensiHuman Institute, ShanghaiTech/Bridge Institute, USCAdresse e-mail validée de usc.edu

Suivre

Newman Amy Hauck

National Institue on Drug Abuse-Intramural Research Program, NIH

Adresse e-mail validée de intra.nida.nih.gov - Page d'accueil

medicinal chemistry addiction dopamine receptors and transporters


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist EYT Chien, W Liu, Q Zhao, V Katritch, G Won Han, MA Hanson, L Shi, ... Science 330 (6007), 1091-1095, 2010	1366	2010
The binding sites for cocaine and dopamine in the dopamine transporter overlap T Beuming, J Kniazeff, ML Bergmann, L Shi, L Gracia, K Raniszewska, ... Nature neuroscience 11 (7), 780-789, 2008	426	2008
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues L Albizu, M Cottet, M Kralikova, S Stoev, R Seyer, I Brabet, T Roux, ... Nature chemical biology 6 (8), 587-594, 2010	394	2010
Current perspectives on selective dopamine D₃ receptor antagonists as pharmacotherapeutics for addictions and related disorders CA Heidbreder, AH Newman Annals of the New York Academy of Sciences 1187 (1), 4-34, 2010	328	2010
Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype C Martinat, JJ Bacci, T Leete, J Kim, WB Vanti, AH Newman, JH Cha, ... Proceedings of the National Academy of Sciences 103 (8), 2874-2879, 2006	272	2006
Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents AH Newman, P Grundt, MA Nader Journal of medicinal chemistry 48 (11), 3663-3679, 2005	219	2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants LK Henry, JR Field, EM Adkins, ML Parnas, RA Vaughan, MF Zou, ... Journal of Biological Chemistry 281 (4), 2012-2023, 2006	214	2006
Molecular determinants of selectivity and efficacy at the dopamine D3 receptor AH Newman, T Beuming, AK Banala, P Donthamsetti, K Pongetti, ... Journal of medicinal chemistry 55 (15), 6689-6699, 2012	193	2012
The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats ZX Xi, AH Newman, JG Gilbert, AC Pak, XQ Peng, CR Ashby, L Gitajn, ... Neuropsychopharmacology 31 (7), 1393-1405, 2006	176	2006
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior GT Collins, JM Witkin, AH Newman, KA Svensson, P Grundt, J Cao, ... Journal of Pharmacology and experimental therapeutics 314 (1), 310-319, 2005	168	2005
Novel heterocyclic trans olefin analogues of N-{4-[4-(2, 3-dichlorophenyl) piperazin-1-yl] butyl} arylcarboxamides as selective probes with high affinity for the dopamine D3 … P Grundt, EE Carlson, J Cao, CJ Bennett, E McElveen, M Taylor, ... Journal of medicinal chemistry 48 (3), 839-848, 2005	165	2005
Synthesis and evaluation of optically pure [³H]‐(+)‐pentazocine, a highly potent and selective radioligand for σ receptors BR de Costa, WD Bowen, SB Hellewell, JM Walker, A Thurkauf, ... FEBS letters 251 (1-2), 53-58, 1989	165	1989
Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens M Besson, D Belin, R McNamara, DEH Theobald, A Castel, VL Beckett, ... Neuropsychopharmacology 35 (2), 560-569, 2010	163	2010
Acute administration of SB‐277011A, NGB 2904, or BP 897 inhibits cocaine cue‐induced reinstatement of drug‐seeking behavior in rats: Role of dopamine D3 receptors JG Gilbert, AH Newman, EL Gardner, CR Ashby Jr, CA Heidbreder, ... Synapse 57 (1), 17-28, 2005	163	2005
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD FH Hansen, T Skjørringe, S Yasmeen, NV Arends, MA Sahai, K Erreger, ... The Journal of clinical investigation 124 (7), 3107-3120, 2014	162	2014
The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders M Mereu, A Bonci, AH Newman, G Tanda Psychopharmacology 229, 415-434, 2013	161	2013
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse CJ Loland, M Mereu, OM Okunola, J Cao, TE Prisinzano, S Mazier, ... Biological psychiatry 72 (5), 405-413, 2012	160	2012
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis AH Newman, BL Blaylock, MA Nader, J Bergman, DR Sibley, P Skolnick Biochemical pharmacology 84 (7), 882-890, 2012	155	2012
The N terminus of monoamine transporters is a lever required for the action of amphetamines S Sucic, S Dallinger, B Zdrazil, R Weissensteiner, TN Jørgensen, M Holy, ... Journal of Biological Chemistry 285 (14), 10924-10938, 2010	155	2010
Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists ABP Fernando, D Economidou, DE Theobald, MF Zou, AH Newman, ... Psychopharmacology 219, 341-352, 2012	152	2012

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs